# Tacurion Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tacurion-pharma

- Industry: Pharmaceuticals
- Headquarters: Bridgewater, US
- Website: www.tacurion.com
- Total disclosed funding: $15M
- Latest round: Series D (Apr 8, 2013)
- Investors on record: 3

## About

Tacurion Pharma, Inc. is a pharmaceutical company dedicated to developing innovative therapeutics to address unmet medical needs, focusing on conditions with significant patient impact.Tacurion Pharma, Inc. specializes in the development of therapeutics with a focus on underserved medical needs. The company is headquartered in Bridgewater, US. In April 2013, Tacurion raised USD 15 mn in Series D funding from investors including Astellas Venture Management, InterWest Partners, and Sutter Hill Ventures, bringing the total amount raised to USD 15 mn and the current company valuation to USD 64.39 mn.Tacurion Pharma, Inc. is engaged in the development of innovative pharmaceutical products aimed at addressing significant medical needs. The company’s portfolio includes various therapies designed for specific health conditions, leveraging advanced research methodologies to ensure efficacy and safety.Tacurion Pharma, Inc. generates revenue primarily through the commercialization of its pharmaceutical products, adopting a business model that fosters direct engagement with healthcare providers and institutions. Revenue growth is supported by successful product launches and ongoing research initiatives that aim to meet the evolving needs of the healthcare sector.Following the recent Series D funding of USD 15 mn in April 2013, Tacurion Pharma, Inc. plans to accelerate the development of its pipeline therapies targeting specific medical conditions. The company is set to expand its market reach into European and Asian regions by 2025, utilizing funding to enhance research capabilities and expand clinical trials for new therapeutic products.

## Funding rounds

- Series D, Apr 8, 2013, $15M — InterWest Partners, Astellas Venture Management, Sutter Hill Ventures

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series D
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series D
- Sutter Hill Ventures (https://capitalatlas.ai/funds/sutter-hill-ventures) — Series D